Clinical Trial Update: Gefitinib in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This update reports on a Phase 2 clinical trial evaluating gefitinib (Iressa) for patients with stage IIIA non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Iressa (gefitinib)

Snippet

Sponsor: Yonsei University | Conditions: Lung Cancer | Phase 2 | Status: UNKNOWN